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Abstract
Tooth agenesis is one of the most common congenital malformations in humans. Hypodontia can either occur as 
an isolated condition (non-syndromic hypodontia) or can be associated with a syndrome (syndromic hypodontia), 
highlighting the heterogeneity of the condition. Though much progress has been made to identify the developmen-
tal basis of tooth formation, knowledge of the etiological basis of inherited tooth loss is still lacking. To date, the 
mutation spectra of non-syndromic form of familial and sporadic tooth agenesis in humans have revealed defects 
in various such genes that encode transcription factors, MSX1 and PAX9 or genes that code for a protein involved 
in canonical Wnt signaling (AXIN2), and a transmembrane receptor of fibroblast growth factors (FGFR1). The aim 
of this paper is to review the current literature on the molecular mechanisms responsible for selective hypodontia 
in humans and to present a detailed overview of causative genes and syndromes associated with hypodontia. 
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Introduction
Hypodontia (dental agenesis) is the most common de-
velopmental anomaly in humans, constituting a clinica-
lly challenging problem. Hypodontia is often used as a 
collective term for congenitally missing teeth, although 
specifically, it describes the absence of one to six teeth, 
excluding third molars. Oligodontia (multiple aplasia) 
refers to the congenital absence of six or more teeth, 
excluding third molars. Anodontia represents a com-
plete failure of one or both dentitions to develop (1). 
Hypodontia is usually associated with other oral ano-
malies, such as cleft lip and/or palate, reduction in size 
and form of teeth and alveolar processes, short root ano-
maly, crowding and/or malposition of other teeth, dela-
yed formation and/or delayed eruption of other teeth, 
persistent deciduous teeth, impaction, anomalies of the 
enamel, increased free-way space, false diastema, deep 
overbite, taurodontism, maxillary canine ⁄ first premolar 
transposition, enamel hypoplasia, and altered craniofa-
cial growth (2-5). 
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Hypodontia can either occur in association with other 
genetic diseases as part of a recognized clinical syn-
drome, or as a non-syndromic, familial form, which 
occurs as an isolated trait, shows a wide phenotypic he-
terogeneity, appears either sporadically or in a familial 
fashion within a family pedigree (6). Although dental 
agenesis is occasionally caused by environmental fac-
tors, such as infection (e.g. rubella), various kinds of 
trauma of the dental region, multi-reagent chemothera-
py or radiotherapy, or disturbances in jaw innervations, 
in a majority of cases, hypodontia has genetic causes 
(1,6). While a number of clinical studies have been ca-
rried out on disorders that involve the congenital lack of 
teeth, until recently, a very little effort has been made 
to understand the genetic module accountable for mam-
malian tooth development. Advancements in molecular 
biology approaches coupled with the now complete hu-
man genome sequence has allowed a number of putati-
ve disease genes/loci associated with the hypodontia/
oligodontia phenotypes to be identified (7). 
The knowledge of the genotype–phenotype correlation 
between mutations and teeth agenesis is important for 
genetic counseling, for a more comprehensive evalua-
tion of the patient, and for anticipating suitable mana-
gement of the dental abnormalities, especially in chil-
dren. 
Stage of tooth development Protein factors involved in 
signaling from epithelium 
Protein factors involved in 
signaling from mesenchyme 
Initiation Stage 
Bud Stage 
Cap Stage 
Bell Stage 
 
Fgfs, Bmps, Shh, Pitx2 and 
Wnts 
 
 
 
 
Bmp, Fgf, Wnts, Shh, Pdgf, 
p21, Msx2, Lef1 and Tgf-? 
 
 
Bmp, Fgf, Wnts, Shh, Pdgf, 
p21, Msx2, Lef1 and Tgf-? 
 
 
Pax9, Ptc, Msx1, Msx2, Bmp4, 
Lhx6, Lhx7, Lef1, Dlx1, 
Dlx2,Gli1,Gli2, Gli3 and Barx1 
 
 
Pax9, Bmp, Dlx1, Dlx2, Lhx6, 
Lhx7, Msx1, Lef1, Gli1,Gli2, Gli3, 
Barx1 and Fgfs 
 
Pax9, Bmp, Dlx1, Dlx2, Lhx6, 
Lhx7, Msx1, Lef1, Gli1,Gli2, Gli3, 
Barx1, Bmp4,  Msx2 and Fgfs 
 
Table 1. Signaling protein factors involved in tooth development, failure of one of which may result in patterning 
defects.
Molecular Mechanisms Involved in Odonto-
genesis
Recently, a number of genes have been identified that are 
involved in tooth morphogenesis and their regulatory 
role throughout the development of the tooth organ, i.e. 
from tooth initiation to tooth patterning (determination 
of the location, identity, size and shape of teeth) and his-
togenesis of the dental tissues has been highlighted (8). 
Previous studies showed that some genes have a strong 
influence on tooth development (MSX1, PAX9, LEF1, 
PITX2), whereas other genes have a less pronounced 
effect (DLX1, DLX2, GLI2, GLI3) (8-10). PAX9 has 
been identified as a key controlling factor during the 
odontogenic process with its expression found specifi-
cally at the prospective sites of all teeth prior to there 
being any morphological signs of odontogenesis (7). A 
general role for MSX1 in the development of ectoder-
mal derivatives has been suggested with it strongly ex-
pressed in the dental mesenchyme (7).
In mammals, tooth development is governed by a se-
quential and reciprocal signaling process between two 
adjacent tissues, the primitive epithelium lining the 
stomodeum and mesenchymal cells arising from cra-
nial neural crest cells (11) (Table 1). The oral epithe-
lium initiates tooth development at embryonic day 9-11 
by signaling through generic molecules such as Fgfs, 
Bmps, Wnt, and Shh and continue to be involved in fur-
ther morphogenesis and cytodifferentiation of the tooth 
(12). Signaling molecules that determine the position 
and the shape of the teeth are MSX1, MSX2, DLX1, 
DLX2, BARX1, and PAX (13). PAX9 and MSX1 have 
been reported to have an important regulatory role in 
the maintenance of BMP4 expression and signaling, 
implying they may also have a role in odontogenic po-
tential shifts (13).
A variety of dental anomalies either morphological, 
numerical, and/or structural in nature may result due 
to abnormal function of these specific proteins. Depen-
ding on the molecule and its timing of required expres-
sion in either (or both) the oral epithelium and adjacent 
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mesenchyme, tooth primordia may be absent (Wnt, 
p63), or tooth development may be arrested at the bud 
stage (Lef1, Msx1, Msx2, Pax9, Pitx2) or at the cap/bell 
stage (Cbfa1/Runx2) (14-19). Studies have shown that 
tooth development is arrested at the bud stage in both 
Pax9 and Msx1 mutant mice (17), suggesting they have 
similar, non-redundant roles in signal progression to the 
cap stage of tooth development. 
Genetics of Human Tooth Agenesis
Modern molecular genetic techniques have helped us to 
identify the genetic factors responsible for tooth age-
nesis and the mechanisms responsible for tooth agene-
sis but more studies are required to discover how mal-
functions in these factors disrupt tooth development. 
Using gene mapping techniques on families known to 
have hypodontia and/or oligodontia investigators have 
been able to definitively link several gene mutations 
with tooth agenesis. 
Non-Syndromic Hypodontia
Non-syndromic hypodontia is by far the most common 
form of congenital tooth absence and can involve va-
riable numbers of teeth. It is more commonly seen in 
the secondary dentition and is rare in primary dentition. 
Non-syndromic hypodontia is classified as a sporadic 
or familial form, inherited in an autosomal-dominant, 
autosomal-recessive or X-linked mode, with considera-
ble variation in both penetrance and expressivity (20). 
To date, the mutation spectra of non-syndromic form of 
familial and sporadic tooth agenesis in humans have re-
vealed defects in various such genes that encode trans-
cription factors, MSX1 and PAX9 or genes that code for 
a protein involved in canonical Wnt signaling (AXIN2), 
and a transmembrane receptor of fibroblast growth fac-
tors (FGFR1) (Table 2). Protein products of genes that 
encode transcription factors - MSX1 and PAX9, are re-
sponsible for the crosstalk between dental tissues and 
are essential for the establishment of the odontogenic 
potential of the mesenchyme (12).
MSX1
MSX1 contains a highly conserved homeobox sequence 
encoding a 60 amino acid-long DNA-binding homeodo-
main (21). MSX1 belongs to a family of transcription fac-
tors that are expressed in overlapping patterns at multiple 
sites of tissue interactions during vertebrate development 
(22). Till date, five point mutations have been identified 
within MSX1 gene mutations, with two leading to a subs-
titution mutation within the protein and the remaining 
three forming a stop codon that prematurely truncates 
the protein. Two mutations fall within the N-terminal re-
gion prior to the central homeodomain (M61K & S105X), 
with the remaining three (Q187X, R196P & S202X) all 
falling within the homeodomain itself.
Of the two substitution mutations, the M61K mutation 
falls outside of the homeodomain of MSX1, and it has 
been reported that it may cause disruption of protein 
interactions. The R196P mutation falls within helix-I 
of the MSX1 homeodomain, disrupting its stability and 
functional activity (23). Of the three premature termi-
nation mutations, S105X is the only mutation to occur 
prior to the homeodomain of MSX1. The remaining two 
termination mutations fall within the central region of 
the MSX1 homeodomain. However, there is no clear co-
rrelation between the severity of the hypodontia and the 
severity of the effect on the MSX1 protein caused by the 
identified missense mutations.
PAX9
PAX9 is a member of a gene family encoding trans-
cription factors that play a key role during embryoge-
nesis. Proteins encoded by PAX genes share a unique 
128-amino acid long DNA-binding paired domain (24). 
PAX9 gene products function primarily by binding the 
enhancer DNA sequences and by modifying transcrip-
tional activity of downstream genes (25). To date, 11 
Gene
involved
Mutations of Genes 
associated with agenesis Defect 
Mode of 
transmission 
MSX1 
PAX9 
AXIN2 
LTBP3
EDA
M61K, S105X, Q187X, 
R196P & S202X 
K114X, L21P, R26W, 
R28P, G51S, K91E, 
G73fsX316,
V265fsX316 & R59fsX177 
Arg656Stop, 1994-
1995insG
              Y774X 
          Thr338Met 
Hypodontia 
Hypodontia 
Oligodontia
Molar hypodontia 
Oligodontia
Peg shaped laterals 
Incisor agenesis 
Oligodontia
Hypodontia 
Autosomal dominant 
Autosomal recessive 
Autosomal dominant 
Autosomal dominant 
Autosomal dominant 
Autosomal dominant 
Uncertain 
Autosomal recessive 
X linked recessive 
Table 2. Genes associated with tooth agenesis in humans.
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distinct disease-causing mutations in the PAX9 gene 
(59 patients in 15 families) have been identified in hu-
mans, most of which are located in the paired box do-
main of PAX9. In contrast to MSX1, both missense and 
frame-shift mutations in PAX9 have been associated 
with hypodontia.
Of the seven identified missense mutations, one is a 
premature termination mutation (K114X), and the re-
maining six are all residue substitution mutations. Of 
these substitution mutations, only five generate a subs-
titution in the protein (L21P, R26W, R28P, G51S & 
K91E), with one believed to prevent PAX9 expression. 
Three frame-shift mutations have been identified, two 
of which are caused by the insertion of a single nucleo-
tide (G73fsX316 & V265fsX316) and the other by the 
deletion of eight nucleotides with the insertion of 288 
foreign nucleotides (R59fsX177) (26). 
The only substitution mutation to cause premature ter-
mination was an A340T switch, which creates a stop co-
don at lysine 114, producing a truncated PAX9 protein 
that terminates at the end of the N-terminal DNA bin-
ding region of the PAX9 paired-box domain (27). The 
remaining three missense mutations (R26W, R28P and 
G51S) that leads to a residue substitution in the PAX9 
protein have been identified recently.
It is significant to note that most of the PAX9 frame-shi-
ft, deletion and missense termination mutations cause 
hypodontia in both the permanent and the primary den-
titions, whereas missense substitution mutations affect 
the permanent dentition only. 
MSX1 and PAX9 
MSX1 and PAX9 interact during odontogenesis at both the 
gene and protein level and are intimately involved in the ge-
netic networks regulating tooth development. PAX9 forms 
a physical association with MSX1, and this interaction 
takes the form of a heterodimeric protein complex, which 
enhances the ability of PAX9 to activate both MSX1 and 
mesenchymal Bmp4 gene expression during tooth develo-
pment. This interaction ultimately drives morphogenesis 
of the dental organ, more in particular, the transition from 
bud to cap stage during tooth development and enamel 
knot induction at the late cap stage (28). 
Besides Bmp4 downregulation, mutations in PAX9 
could result in a selective reduction in PAX9 binding to 
sites that regulate MSX1 expression levels. Mutations 
in either PAX9 or MSX1 can also lead to defective pro-
tein–protein interactions, both at the gene and protein 
levels that disrupt normal downstream functions impor-
tant for tooth morphogenesis (28).
Haploinsufficiency of MSX1 protein affects the deve-
lopment of all teeth, specifically third molars and se-
cond premolars, while reduced amount of PAX9 protein 
mainly affects molar development. 
AXIN2
AXIN2 or axis inhibitor protein 2 is a gene located on 
the long arm of chromosome 17 with a genetic address 
of 17q23-q24. The association of the gene to tooth age-
nesis was first found in a Finnish family with a predis-
position for colorectal cancer (29). The mutations of 
AXIN2 -Arg656Stop and 1994-1995insG lead to decrea-
sed AXIN2 function and most probably represent loss-
of-function mutations that cause activation of Wnt signa-
ling. AXIN2 was selected as a strong candidate gene for 
several reasons: Its position within this particular chro-
mosomal region, a previously identified association with 
colorectal carcinoma and the fact that AXIN2 is also a 
known regulator of the Wnt signalling pathway. The Wnt 
family of secreted proteins forms part of a large family 
of signalling molecules that have a wide-ranging role du-
ring embryonic development and demonstrate regionally 
restricted expression in the tooth (30). 
The mode of transmission of hypodontia due to defects 
in the AXIN2 gene has not been definitively proven, 
and it has been seen that individuals with a non-sense 
mutation in AXIN2 display a mixed pattern of dental 
agenesis.
LTBP3
LTBP3 (latent transforming growth factor beta binding 
protein 3) is a gene that modulates the bioavailability 
of TGF-beta and is located on the long arm of chromo-
some 11. A study on a Pakistani family with a history 
of consanguineous marriage found that a mutation in 
the LTBP3 gene causes an autosomal recessive form of 
familial oligodontia (31).
EDA 
EDA (ectodysplasin 1) is a gene located at Xq12-q13.1 
that has been linked to X-linked recessive ectodermal 
dysplasia. A study of Chinese families with non syn-
dromic X-linked hypodontia has shown that a Thr338-
Met mutation of the EDA gene was responsible for the 
congenital absence of maxillary and mandibular central 
incisors, lateral incisors, and canines, with the high pos-
sibility of persistence of maxillary and mandibular first 
permanent molars (32).
Syndromic Conditions Associated with Dental 
Agenesis
Online Mendelian Inheritance in Man (OMIM) lists 
over 60 different syndromic conditions that include 
hypodontia as part of their phenotypic spectrum of 
anomalies and candidate genes have been identified for 
many of these conditions (Table 3). Ectodermal dyspla-
sia, oral-facial-digital syndromes, and syndromes with 
oral-facial clefting such as Pierre-Robin sequence and 
Van Der Woude syndrome are conditions, which are 
associated with hypodontia. Successive linkage analy-
sis studies have indicated involvement of different loci, 
mapped respectively to chromosome 6p24; 2p13; 19q13; 
and regions on 4q, in non-syndromic cleft lip and ⁄ or pa-
late (CL/CLP) (33). In Pierre- Robin syndrome, a 50% 
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Syndrome Genes and gene locus involved 
OMIM Entry 
(Online Mendelian 
Inheriance in Man 
Aarskog syndrome Translocation of 8p and Xq 100050 
ADULT syndrome TP73L (3q27) 103285 
Alagile syndrome JAG1 (20p12) 118450 
Apert syndrome FGFR2 (10q26) 101200 
Blepharo-cheilo-odontic syndrome unknown 119580 
Branchio-oto-renal  syndrome, Type I EYA1 (8q13.3) 113650 
Charcot-Marie-Tooth disease, Type 
2E NEFL (8p21) 607684 
Cleft lip  palate - ectodermal 
dysplasia syndrome PVRL1 (11q23-q24) 225060 
Coffin-Lowry syndrome RSK2 (Xp22.2-p22.1) 303600 
Crouzonodermoskeletal syndrome FGFR3 (4q16.3) – 
Down syndrome chromosome 21 trisomy 190685 
Dubowitz syndrome unknown 223370 
Ectodermal dysplasia, tricho-odonto-
onychial type unknown 129510 
Ectodermal dysplasia, AD 
hypohidrotic type EDAR (2q11-q13) 129490 
Ectodermal dysplasia, AR 
hypohidrotic type 
EDAR (2q11-q13), EDARADD 
(1q42.2-q42.3) 224900 
Ectodermal dysplasia, XD 
hypohydrotic type EDA (Xq12-q13.1) 305100 
EEC syndrome P68 (3q27), (7q11.2-q21.3) 129900, 604273 
Ehlers-Danlos hypermobility type COL3A1 (2q31) 130020 
Ehlers-Danlos s., dermatosparaxis 
type ADAMTS2 (5q23) 225410 
Ellis-van Creveld s. 
(chondroectodermal dysplasia) EVC EVC2 (4p16) 225500 
Fanconi renotubular syndrome (15q15.3) 13600 
Frontometaphyseal dysplasia FLNA (Xq28) 305620 
GAPO syndrome unknown 230740 
Goldenhar syndrome unknown 164210 
Goltz-Gorlin syndrome (focal dermal 
hypoplasia) unknown 305600 
Hallermann-Streiff syndrome unknown 234100 
Hanhart syndrome unknown 103300 
Hay-Wells syndrome TP73L (3q27) 106260 
Incontinentia pigmenti IKK? (NEMO) (Xq28) 308300 
Johanson-Blizzard syndrome UBR1 (1515-q21.1) 243800 
Kabuki syndrome unknown 147920 
Kartagener syndrome DNAI1 (9p21-p13), DNAH5 (5p15-p14), DNAHC11 (7p21) 244400 
KBG syndrome unknown 148050 
Table 3. Syndromes associated with hypodontia.
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Levy-Hollister syndrome FGFR2 (10q26), FGFR3 (4p16.3), 
FGF10 (5p13-p12) 
149730
Larsen syndrome FLNB (3p14.3) 150250 
Laurence-Moon syndrome MKKS (20p12) 245800 
Moebius syndrome (13q12.2-q13) 157900 
Mulvihill-Smith syndrome unknown 176690 
Neu-Laxova syndrome unknown 256520 
Oral-facial-digital syndrome Type I CXORF5 (Xp22.3-p22.) 311200 
Pseudoxanthoma elasticum ABCC6 (16p13.1) 26400 
Rapp-Hodgkin syndrome TP73L (3q27) 129400 
Rieger syndrome, Type I PITX2 (4q25-q26) 180500 
Rieger syndrome, Type II RIEG2 (13q14) 601499 
Rothmund-Thomson syndrome RECQL4 (8q24.3) 268400 
Rubinstein-Taybi syndrome CREBBP (16p13.3), EP300 (22q13) 180849 
Schwartz-Jampel syndrome HSPG2 (1p36.1) 255800 
Seckel syndrome. ATR (3q22.1-q24), (18p11q11), 210600
Sickle cell anemia (14q) 603903 
Sjogren-Larsson syndrome. HBB⁄HbSC (11p15.5) 270200 
Smith-Magenis syndrome ALDH3A2 (17p11.2) 182290 
Sotos syndrome RAI1 (17p11.2) (5q35)
117550
183600
Split-hand ⁄ foot malformation SHFM1 (7q21), SHFM2 (Xq26),SHFM3 
(10q24), SHFM4 (3q27), SHFM5 (2q31) 
211370
Tuomaala-Haapanen syndrome unknown 119300 
Van der Woude syndrome IRF6 (1q32-q41) 193500 
Waardenburg syndrome, Type I PAX3 (2q35) 277600 
Weill-Marchesani syndrome ADAMTS10 (19p13.3-p13.2) 193530 
Weyers acrofacial dysostosis EVC (4p16) ELN (7q11.2), LIMK1 ⁄RFC2
⁄CYLN2⁄GTF2IRD1 ⁄GGTF2I (7q11.23) 194050
Williams syndrome MSX1 (4p16.1) 189500 
Witkop tooth-and-nail syndrome deletion of short arm of chromosome 4 194190 
Wolf-Hirschhorn syndrome unknown 602361 
Yunis-Varon
del(22q) syndrome deletion of long arm of chromosome 22 – 
Table 3. Continue
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prevalence of hypodontia, most frequently of mandibu-
lar teeth, while in Van Der Woude syndrome (VWS), a 
70% prevalence of hypodontia has been reported. Mu-
tations in IRF6 (1q32-q41) have been identified in 50 
unrelated families with VWS (34).
Ectodermal dysplasia (ED) which is classified into 11 
clinical subgroups displays a great genetic heteroge-
neity. X-linked dominant ED is caused by mutations 
in EDA gene (Xq12-q13.1). Both autosomal dominant 
and recessive forms of ED are caused by mutations in 
EDAR (2q11-q13) coding for a TNF receptor (35). Se-
veral different mutations of P68 gene (3q27), linkage 
to chromosome 7 (7q11.2-q21.3) and the chromosome 
19 pericentromeric region have been revealed in ectro-
dactyly ectodermal dysplasia – orofacial cleft (EEC) 
syndrome families (36,37). Oral-facial-digital syndro-
me type I (OFD1) transmitted as an X-linked dominant 
condition has been associated with several mutations in 
CXORF5 (Xp22.3-p22.2) (38).
Mutations in MSX1 gene (on 4p16.1) have been iden-
tified in several unrelated families with Witkop tooth-
and-nail syndrome. Hypodontia features in a number 
of other syndromes such as Rieger’s syndrome, Oculo-
facial-cardio-dental syndrome, Incontinentia pigmenti, 
Pierre Robin sequence, Fried syndrome, Book syndro-
me, Down’s syndrome, Wolf-Hirschhorn syndrome, 
Kabuki syndrome, Diastrophic dysplasia (DTD), He-
mifacial microsomia and Recessive incisor hypodontia 
(RIH) (Table 3).
Conclusions and Future Perspectives
Tooth agenesis is genetically and phenotypically a he-
terogeneous condition, caused by several independent 
defective genes, which act along or in combination with 
other genes and lead to specific phenotypes. During 
the past decades, significant efforts have been made for 
detecting gene loci that contributes to dental agenesis. 
However, there is a dearth of knowledge of the genetic 
epidemiology of dental agenesis and only few genoty-
pe-phenotype correlations have yet been established in 
humans with non-syndromic hypodontia. 
Further research of genetic and pathogenetic mecha-
nisms involved in both syndromic, and non-syndromic 
hypodontia is warranted to shed light into the pathoge-
nesis of tooth agenesis, to describe the pattern of oc-
currence and of the malformations found on the teeth 
present. 
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